Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan

Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan

Several genetic variants have been identified that cause variation among different populations and even within individuals of a similar descent. This leads to interindividual variations in the optimal dose of the drug that is required to sustain the treatment efficiency. In this study, 56 single nuc...

Full description

Bibliographic Details
Main Authors:	Laith N. AL-Eitan, Doaa M. Rababa’h, Nancy M. Hakooz, Mansour A. Alghamdi, Rana B. Dajani
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Series:	Journal of Personalized Medicine
Subjects:	pharmacogenomics vip polymorphism phase i enzymes phase ii enzymes metabolizing
Online Access:	https://www.mdpi.com/2075-4426/10/1/2

Similar Items

Analysis of Comprehensive Pharmacogenomic Profiling of VIP Variants Among the Genetically Isolated Chechen Subpopulation from Jordan
by: AL-Eitan LN, et al.
Published: (2020-07-01)

Genetic variants of vascular endothelial growth factor-634 and vascular endothelial growth factor-936 in Circassians and Chechens subpopulations in Jordan
by: Tamara Al-Daghastani, et al.
Published: (2023-06-01)

Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population
by: He C, et al.
Published: (2021-08-01)

Genetic Variation among Pharmacogenes in the Sardinian Population
by: Maria Laura Idda, et al.
Published: (2022-09-01)

Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China
by: Wanlu Chen, et al.
Published: (2019-09-01)

Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population
by: Cheng Y, et al.
Published: (2021-10-01)

A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact
by: Rocio Nunez-Torres, et al.
Published: (2023-04-01)

by: Shabbir Ahmed, et al.
Published: (2016-10-01)

Editorial: Genetics and ontogeny in precision therapeutics for children
by: Feng Chen, et al.
Published: (2023-10-01)

Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China
by: Wang Y, et al.
Published: (2021-12-01)

Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes
by: Megan L. Hutchcraft, et al.
Published: (2021-09-01)

Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency
by: Vid Matišić, et al.
Published: (2023-08-01)

Regulation of Human Endogenous Metabolites by Drug Transporters and Drug Metabolizing Enzymes: An Analysis of Targeted SNP-Metabolite Associations
by: Jeffry C. Granados, et al.
Published: (2023-01-01)

Polyphenols of Salix aegyptiaca modulate the activities of drug metabolizing and antioxidant enzymes, and level of lipid peroxidation
by: Mohd Nauman, et al.
Published: (2018-03-01)

The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression
by: Henok D. Habtemariam, et al.
Published: (2022-02-01)

Learning from biomedical linked data to suggest valid pharmacogenes
by: Kevin Dalleau, et al.
Published: (2017-04-01)

Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study
by: Laith N. AL-Eitan, et al.
Published: (2019-12-01)

Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
by: R. van Westrhenen, et al.
Published: (2021-09-01)

Tuning Immobilized Commercial Lipase Preparations Features by Simple Treatment with Metallic Phosphate Salts
by: José R. Guimarães, et al.
Published: (2022-07-01)

Further Stabilization of Alcalase Immobilized on Glyoxyl Supports: Amination Plus Modification with Glutaraldehyde
by: Fouzia Hussain, et al.
Published: (2018-12-01)

THE MANAGEMENT OF VIP-SYNDROME
by: R. M. Tikhilov, et al.
Published: (2012-06-01)

Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2 and UGT2B7: potential effect on regulation by microRNA and pharmacogenomics relevance
by: Marelize eSwart, et al.
Published: (2014-06-01)

Enzymes from genetically modified microorganisms. /
by: 422343 Pedersen, Sven, et al.

Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: Perspectives in maintaining the antioxidant activity of vitamins A, C, and E
by: Sekhar s Boddupalli, et al.
Published: (2012-01-01)

Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
by: Tristan M. Sissung, et al.
Published: (2022-02-01)

Pharmacogenomic study reveals new variants of drug metabolizing enzyme and transporter genes associated with steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in Thai autism spectrum disorder patients
by: Sadeep Medhasi, et al.
Published: (2016-12-01)

Enzyme assays : high-throughput screening, genetic selection and fingerprinting /
by: Reymond, Jean-Louis
Published: (2006)

Dietary moderately oxidized oil activates the Nrf2 signaling pathway in the liver of pigs
by: Varady Juliane, et al.
Published: (2012-02-01)

Genetic Polymorphisms of Pesticide-Metabolizing Enzymes and Transporters in Agricultural Workers and Thyroid Hormone Levels
by: Sirivarasai J, et al.
Published: (2021-08-01)

Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics
by: Alireza Tafazoli, et al.
Published: (2023-07-01)

Two-Phase Biocatalysis in Microfluidic Droplets
by: Lanting Xiang, et al.
Published: (2021-10-01)

Short-Term Clinical Outcomes of Packed Red Blood Cell Transfusions with Isolated Enzyme-Phase Crossmatch Incompatibility: A Single-Center Cross-Sectional Study
by: Umut Yılmaz, et al.
Published: (2023-03-01)

DESEMPENHO E AVALIAÇÃO DA CARCAÇA EM SUÍNOS ALIMENTADOS COM RAÇÕES DE TERMINAÇÃO COM FITASE ASSOCIADA À RETIRADA DE MICROMINERAIS, VITAMINAS E FÓSFORO INORGÂNICO
by: Ana Paula Azara de Oliveira, et al.
Published: (2010-12-01)

Organo-gel de heptano: diagrama de fases e aplicações sintéticas
by: Queiroz Neide, et al.
Published: (1999-01-01)

Comparative biodistribution profile of [131I]VIP and [131I]VIP10-28
by: Maria Tereza Colturato, et al.
Published: (2005-10-01)

Vegetative Insecticidal Protein (Vip): A Potential Contender From Bacillus thuringiensis for Efficient Management of Various Detrimental Agricultural Pests
by: Mamta Gupta, et al.
Published: (2021-05-01)

Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H:quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials
by: Kim S, et al.
Published: (2017-11-01)

Inaccuracies in plasma oxytocin extraction and enzyme immunoassay techniques
by: Hoong-Wei Gan, et al.
Published: (2023-08-01)

The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation
by: Alexandra Brady, et al.
Published: (2023-08-01)

Intensification of β-glucosidase enzyme production from Aspergillus niger using extractive fermentation with an aqueous two-phase system
by: Dhage Avinash B., et al.
Published: (2017-08-01)